PREDIERI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 36.378
EU - Europa 29.924
AS - Asia 19.410
SA - Sud America 2.406
Continente sconosciuto - Info sul continente non disponibili 851
AF - Africa 500
OC - Oceania 184
Totale 89.653
Nazione #
US - Stati Uniti d'America 35.395
IT - Italia 13.785
SG - Singapore 6.367
GB - Regno Unito 4.974
CN - Cina 4.777
SE - Svezia 3.484
HK - Hong Kong 2.300
DE - Germania 1.778
BR - Brasile 1.725
VN - Vietnam 1.705
FI - Finlandia 1.239
FR - Francia 1.017
BD - Bangladesh 956
UA - Ucraina 803
RU - Federazione Russa 719
KR - Corea 589
TR - Turchia 587
IN - India 550
CA - Canada 500
NL - Olanda 409
ID - Indonesia 317
BG - Bulgaria 307
JP - Giappone 225
AR - Argentina 210
MX - Messico 210
ES - Italia 199
IE - Irlanda 192
CH - Svizzera 158
PL - Polonia 153
AU - Australia 146
PK - Pakistan 146
ZA - Sudafrica 146
IQ - Iraq 143
EC - Ecuador 116
IR - Iran 97
BE - Belgio 94
EG - Egitto 91
LT - Lituania 90
MY - Malesia 84
AT - Austria 82
VE - Venezuela 81
DK - Danimarca 79
CO - Colombia 77
BZ - Belize 75
AE - Emirati Arabi Uniti 72
CL - Cile 65
CZ - Repubblica Ceca 55
PH - Filippine 54
TH - Thailandia 54
PT - Portogallo 47
RO - Romania 46
SA - Arabia Saudita 46
UZ - Uzbekistan 46
MA - Marocco 45
PE - Perù 45
PY - Paraguay 41
TW - Taiwan 40
GR - Grecia 37
NZ - Nuova Zelanda 37
DZ - Algeria 36
JO - Giordania 36
TN - Tunisia 36
CR - Costa Rica 35
NP - Nepal 35
JM - Giamaica 32
KE - Kenya 32
IL - Israele 31
ET - Etiopia 27
AZ - Azerbaigian 23
BO - Bolivia 22
RS - Serbia 22
HU - Ungheria 21
AL - Albania 19
DO - Repubblica Dominicana 19
HN - Honduras 19
NG - Nigeria 18
GT - Guatemala 17
KZ - Kazakistan 17
UG - Uganda 16
UY - Uruguay 16
NO - Norvegia 15
NI - Nicaragua 14
EU - Europa 13
PA - Panama 13
SM - San Marino 13
KW - Kuwait 11
OM - Oman 11
SV - El Salvador 11
TT - Trinidad e Tobago 11
CY - Cipro 10
EE - Estonia 10
SI - Slovenia 10
LB - Libano 9
SK - Slovacchia (Repubblica Slovacca) 9
AM - Armenia 8
GE - Georgia 8
LV - Lettonia 8
MT - Malta 8
PR - Porto Rico 8
PS - Palestinian Territory 8
Totale 88.644
Città #
Singapore 4.279
Ashburn 3.484
Santa Clara 3.361
Southend 3.321
Fairfield 2.256
Hong Kong 2.217
San Jose 1.983
Stockholm 1.810
Chandler 1.625
Woodbridge 1.604
Houston 1.578
Hefei 1.418
Jacksonville 1.370
Council Bluffs 1.175
Dearborn 1.131
Milan 1.124
Rome 1.007
Helsinki 939
Nyköping 888
Ann Arbor 859
Seattle 858
London 855
Beijing 850
Wilmington 818
Cambridge 693
New York 636
Los Angeles 612
Seoul 539
Ho Chi Minh City 525
The Dalles 518
Naples 424
Hanoi 385
Munich 377
Bologna 373
Chicago 332
Princeton 325
Lauterbourg 294
Sofia 287
Modena 286
Buffalo 278
Palermo 270
San Diego 256
Eugene 254
Turin 249
Dallas 227
Columbus 224
Shanghai 224
Jakarta 220
Redwood City 217
Moscow 214
Izmir 208
Orem 196
Frankfurt am Main 195
Bremen 187
Bari 186
São Paulo 167
Florence 160
Dublin 152
Boardman 150
Catania 146
Tokyo 133
Toronto 130
Padova 121
Verona 120
Parma 109
Phoenix 102
Fremont 99
Chennai 98
Des Moines 97
Salt Lake City 97
Warsaw 96
Montreal 95
Johannesburg 94
Las Vegas 92
Da Nang 87
Atlanta 83
Albuquerque 80
Genoa 80
Guangzhou 78
Tampa 78
Amsterdam 75
Belize City 74
Brescia 74
Haiphong 72
Nuremberg 71
Falls Church 70
Brooklyn 68
Denver 66
Mexico City 66
Mumbai 63
Pescara 62
Dong Ket 61
Nanjing 61
Paris 61
Rio de Janeiro 61
Turku 59
Cagliari 56
Philadelphia 56
Poplar 55
Redondo Beach 55
Totale 55.051
Nome #
CASO CLINICO: SINDROME DA MICRODELEZIONE 16p11.2 PROSSIMALE 4.981
"Balanced translocation" T(3;11)(P21;Q13) in a lipoma from a girl with suspected MEN 1 Syndrome. 2.008
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.205
Diabete tipo 2 e obesità pediatrica: rassegna a cura dei Gruppi di Studio Obesità Infantile e Diabete della Società Italiana di Endocrinologia e Diabetologia Pediatrica 1.203
I DISORDINI DELLO SVILUPPO SESSUALE E LE MALFORMAZIONI DELL’APPARATO GENITALE 951
Si può “Valere” di più: un progetto italiano studia i disturbi alimentari negli adolescenti con diabete tipo 1. Dati preliminari 867
Gestione del Covid-19 in età pediatrica: documento di consenso 796
Effetti degli interferenti endocrini su crescita e sviluppo puberale 709
BODY EMOTIONAL MAP: STRUMENTO INNOVATIVO ED UTILE PER MIGLIORARE L’ADATTAMENTO DEI GENITORI ALLA DIAGNOSI DI DIABETE DI TIPO 1 DEL LORO BAMBINO 661
Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes 651
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 534
Lactobacillus reuteri oral administration improves periodontal disease in children and adolescents with type 1 diabetes 503
COMPLICANZE MACROVASCOLARI E MORTALITÀ NEL DIABETE TIPO 1 500
Oral Administration of Lactobacillus Reuteri Improves Periodontal Disease in Children and Adolescents with Type 1 Diabetes 482
IPERTENSIONE IN BAMBINI ED ADOLESCENTI AFFETTI DA DIABETE DI TIPO 1: ALTA PREVALENZA IDENTIFICATA TRAMITE L’UTILIZZO DEL MONITORAGGIO PRESSORIO AMBULATORIALE 430
MALATTIA PARODONTALE IN BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1: EFFICACIA DELLA SOMMINISTRAZIONE ORALE DI LACTOBACILLUS REUTERI 425
Hypospadias: clinical approach, surgical technique and outcome. Twenty years’ experience of a single centre 425
High basal serum allopregnanolone levels in overweight girls 419
Long-term effects on growth, development, and metabolism of ALL treatment in childhood 397
Accuracy of SenseWear Pro2 armband to predict resting energy expenditure in childhood obesity. 396
The Effect of GnRH-Analogue Therapy on the Quality of Life of Patients with Central Precocious Puberty and their Families 395
Endothelial and heart dysfunction in children and adolescents with type 1 diabetes 394
THE IMPACT OF SENSOR-AUGMENTED INSULIN PUMP (SAP) THERAPY ON QUALITY OF LIFE (QOL) IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (T1D) AND THEIR PARENTS 393
Alti livelli di anticorpi antitransglutaminasi predicono la malattia celiaca in bambini e adolescenti italiani con diabete mellito tipo 1. 393
IMPATTO DELLA TERAPIA CON ANALOGO DEL GNRH SULLA QUALITÀ DELLA VITA DEI PAZIENTI CON CPP E DELLE LORO FAMIGLIE 392
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: An Italian cohort study 391
Diabetic ketoacidosis at the onset of disease during a national awareness campaign: a 2-year observational study in children aged 0-18 years 391
CONSEGUENZE METABOLICHE A BREVE E LUNGO TERMINE IN PAZIENTI CON PUBERTÀ PRECOCE CENTRALE TRATTATI CON GNRHA IN ETÀ EVOLUTIVA: STUDIO LONGITUDINALE MONOCENTRICO 387
Effects of Exercise in Children and Adolescent with Type 1 Diabetes Mellitus 386
Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: a long term follow up study. 384
Childhood obesity and environmental pollutants: a dual relationship 382
Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment. 381
DETERMINANTI DELLA HEALTH RELATED QUALITY OF LIFE (HRQOL) IN ADOLESCENTI OBESI ITALIANI 378
A 1-year long-term study on efficacy and safety of degludec in children and adolescents with type 1 diabetes 373
Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study 372
Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: The RIDI study 370
Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting 369
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 368
L’ipercolesterolemia familiare: terapia farmacologica 352
Dolore addominale acuto nelle adolescenti: le principali patologie di natura ginecologica 348
Low serum allopregnanolone levels in girls with precocious pubarche 346
Brain-derived neurotrophic factor and epilepsy: a systematic review 346
Effect of Weight Loss on Markers of Inflammation and Endothelial Function in Childhood Obesity 344
Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes 342
Approaches to dyslipidemia treatment in children and adolescents 339
Growth hormone impaired secretion and antipituitary antibodies in patients with coeliac disease and poor catch-up growth after a long gluten-free diet period: a causal association? 339
Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED. 326
QUALITÀ DI VITA E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 E NEI LORO GENITORI PRIMA E DOPO IL LOCKDOWN PER COVID-19. 326
VALUTAZIONE AUXO-ENDOCRINOLOGICA DEI PAZIENTI AFFETTI DA SICKLE CELL DISEASE (SCD): DATI PRELIMINARI 325
Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program 317
The Role of Nutrition on Thyroid Function 315
A Multicenter Retrospective Survey regarding Diabetic Ketoacidosis Management in Italian Children with Type 1 Diabetes 313
Endocrine immune-related adverse effects of immune-checkpoint inhibitors 312
EFFICACIA E SICUREZZA DI DEGLUDEC NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 312
COVID-19 and Type 1 Diabetes: Concerns and Challenges 311
Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: A review 309
Prevalence and risk factors for microalbuminuria in children and adolescents with type 1 diabetes: long-term experience of a single centre 308
High prevalence of hypertension in children and adolescents with type 1 diabetes identified through the 24 hours ambulatory blood pressure monitoring 306
Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature 306
Insulin pump failures in Italian children with Type 1 diabetes: retrospective 1-year cohort study 303
Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. 302
Efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes 302
Obesity in pediatric age: The analysis of genomic rearrangements 302
SHORT STATURE HOMEOBOX-CONTAINING GENE AND IDIOPATHIC SHORT STATURE 300
Basi genetiche ed aspetti terapeutici delle ipercolesterolemie familiari 297
Plasma brain-derived neurotrophic factor concentrations in children and adolescents. 297
Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic 297
Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study 296
Health-Related Quality of Life and Metabolic Control in Immigrant and Italian Children and Adolescents with Type 1 Diabetes and in their Parents 296
Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients 295
Longitudinal study of the endothelial function in children and adolescents affected by type 1 diabetes mellitus 294
Weekend-Based Parent-Group Intervention to Reduce Stress in Parents of Children and Adolescents with Type 1 Diabetes: A Pilot Study 294
Health-related quality of life and metabolic control in young patients with type 1 diabetes and in their parents before and after the COVID-19 lockdown 293
Relationship between body mass index and insulin measured during oral glucose tolerance testing in severely obese children and adolescents 292
Lipide profile, antioxidant factors and endothelial function in children and adolescent with type 1 diabetes mellitus 292
Endocrine Disrupting Chemicals and Type 1 Diabetes 288
High levels of serum perfluorinated compounds in children with endocrine autoimmune disease. 286
Efficacy and Safety of Degludec in Children and Adolescents with Type 1 Diabetes 283
Endocrine-disrupting chemicals and their effects during female puberty: A review of current evidence 282
MicroRNAs change and target key regulatory genes involved in longitudinal growth in patients with idiopathic isolated growth hormone deficiency (IGHD) on growth hormone (GH) treatment 281
Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry 280
Markers of Inflammation and Endothelial Dysfunction in Young Survivors from Acute Lymphoblastic Leukemia 279
Low-density lipoprotein oxidizability in children with chronic renal failure 278
Hypercholesterolemia in Childhood 278
Evaluation of Bone Mineral Density in a Cohort of Children with Growth Hormone Deficiency 278
Health-Related Quality of Life and Diabetes Control in Immigrant and Italian Children and Adolescents with Type 1 Diabetes and in their Parents 278
Auxological data and glycemic control in children and adolescents with type 1 diabetes 2-years after the COVID-19 pandemic 277
Efficacy of telemedicine in patients with type 1 diabetes over the second year by the COVID-19 pandemic spread 277
A new device for measuring resting energy expenditure in severely obese children and adolescents with and without non-alcoholic fatty liver disease. 276
Thirty-year persistence of obesity after presentation to a pediatric obesity clinic. 276
Elevata incidenza di Diabete tipo 1 tra i bambini di famiglie migranti provenienti dal Nord Africa nella regione Emilia Romagna. 276
A nationwide survey of Italian pediatric diabetologists about COVID-19 vaccination in children and adolescents with type 1 diabetes 276
Human amniotic epithelial cells (HAECs): a reliable source of insulin producing cells? 275
Natural history of congenital hypothyroidism in the last two decades: what is changing? Experience of a single tertiary Italian paediatric centre 274
Complex disease phenotype revealed by GH deficiency associated with a novel and unusual defect in the GH-1 gene. 273
Confocal microscopy: Improving our understanding of nevogenesis 272
IDENTIFICAZIONE PRECOCE DEL DANNO RENALE IN PAZIENTI PEDIATRICI ED ADOLESCENTI AFFETTI DA DREPANOCITOSI.RUOLO DELLA CISTATINA-C 272
Tracheobronchial anomalies in chromosome 22q11.2 microdeletion 271
Impaired GH Secretion in Patients with SHOX Deficiency and Efficacy of Recombinant Human GH Therapy. 271
Extra Uterine Growth Restriction (EUGR) in very low birth weight infants: Growth recovery and neurodevelopment by the corrected age of 2 years old 271
Totale 43.964
Categoria #
all - tutte 293.905
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 293.905


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.191 0 0 466 561 343 392 309 405 625 466 933 691
2022/20237.655 723 631 466 588 825 923 366 760 927 382 600 464
2023/20247.290 389 447 495 698 983 694 585 870 416 427 571 715
2024/202515.136 572 469 440 1.066 2.521 2.130 1.193 874 1.973 920 1.335 1.643
2025/202628.565 1.631 972 2.031 2.832 3.901 2.037 3.590 1.304 3.980 2.516 2.041 1.730
2026/20273.290 1.168 1.962 160 0 0 0 0 0 0 0 0 0
Totale 89.653